These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 8961963)
41. Modifying risks of secondary leukemias: is drug scheduling important? Karp JE; Smith MA J Natl Cancer Inst; 1996 Dec; 88(24):1787-9. PubMed ID: 8961963 [No Abstract] [Full Text] [Related]
42. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results]. Haase D; Hanf V; Schulz T Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180 [TBL] [Abstract][Full Text] [Related]
44. A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias. Ellis M; Ravid M; Lishner M Leuk Lymphoma; 1993 Sep; 11(1-2):9-13. PubMed ID: 8220158 [TBL] [Abstract][Full Text] [Related]
45. Leukemia after chemotherapy for cancer. Chasen MR; Falkson G Cancer Biother; 1993; 8(2):115-22. PubMed ID: 7804352 [No Abstract] [Full Text] [Related] [Previous] [New Search]